# Selective Lipopolysaccharide Hemosorption in Maternal Sepsis

> **NCT05711901** · NA · COMPLETED · sponsor: **Efferon JSC** · enrollment: 30 (actual)

## Conditions studied

- Maternal sepsIs

## Interventions

- **DEVICE:** Efferon LPS

## Key facts

- **NCT ID:** NCT05711901
- **Lead sponsor:** Efferon JSC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05711901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05711901, "Selective Lipopolysaccharide Hemosorption in Maternal Sepsis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05711901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*